Astera Labs, Inc. (ALAB)
NASDAQInformation TechnologySemiconductorsSnapshot 2026-09-04
$310.40+9.75%
Close 2026-09-04 · 1-day change
NASDAQInformation TechnologySemiconductorsSnapshot 2026-09-04
Broken: Primary pillar broken — EPS between $0.44 and $0.46 in 2026-Q2: EPS $0.80 vs $0.44-$0.46 target.
Astera Labs grows revenue from $270.6M in 2025-Q4 to $308.4M in 2026-Q1. It targets $355M-$365M revenue and 73% gross margin in 2026-Q2. EPS is expected to rise to $0.44-$0.46 in 2026-Q2. New Scorpio switching products support growth.
The recent 11.5% one-day stock drop shows market doubts. Insider selling raises confidence concerns. High valuation with PE of 180.6 risks a correction if growth slows.
The market expects about 71% revenue growth next year and values the stock above our fair value by 17%. Our fair value is below the Street median, reflecting caution on the high PE and growth sustainability.
Breaks if: EPS falls below $0.44 in 2026-Q2
Breaks if: Gross margin falls below 70% in 2026-Q2
Breaks if: Failure to gain market traction or revenue from Scorpio products
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
This investment represents a durable compounder with a focus on technology and innovation. The current thesis state is intact, supported by robust earnings quality and a stable management team.
The market currently prices ALAB at a premium compared to its peers, reflecting high expectations for its growth potential. There is a low fragility tier, indicating that the current valuation does not assume significant risk.
Fundamentals are likely to remain strong, driven by management's focus on revenue growth through AI and product expansion. However, there is a slight risk of margin normalization, as gross margins have declined recently.
The long-term thesis hinges on management's ability to maintain revenue growth and gross margins. Additionally, external factors such as potential Fed rate cuts and performance from sector leaders will play a crucial role in shaping future outcomes.
The most important moves since the prior daily snapshot.
Yes, our read has strengthened. The latest earnings beat supports this improved outlook. The company reported a 104% year-over-year revenue growth, indicating strong financial performance. There are no new threats identified that could weaken this positive view.
as of 2026-09-04
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Breaks if: Revenue falls below $355M in 2026-Q2
Astera Labs aims to achieve revenue within the range of $355 million to $365 million for the second quarter of 2026.
Overall, ALAB's strong management and recent financial performance support a positive long-term view. Not investment advice.